Correlation Between Utah Medical and Bionano Genomics
Can any of the company-specific risk be diversified away by investing in both Utah Medical and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Utah Medical Products and Bionano Genomics, you can compare the effects of market volatilities on Utah Medical and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and Bionano Genomics.
Diversification Opportunities for Utah Medical and Bionano Genomics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Utah and Bionano is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Utah Medical i.e., Utah Medical and Bionano Genomics go up and down completely randomly.
Pair Corralation between Utah Medical and Bionano Genomics
Given the investment horizon of 90 days Utah Medical Products is expected to generate 0.26 times more return on investment than Bionano Genomics. However, Utah Medical Products is 3.83 times less risky than Bionano Genomics. It trades about -0.04 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.15 per unit of risk. If you would invest 8,638 in Utah Medical Products on November 2, 2024 and sell it today you would lose (2,516) from holding Utah Medical Products or give up 29.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Utah Medical Products vs. Bionano Genomics
Performance |
| Timeline |
| Utah Medical Products |
| Bionano Genomics |
Utah Medical and Bionano Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Utah Medical and Bionano Genomics
The main advantage of trading using opposite Utah Medical and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.| Utah Medical vs. Precision Optics, | Utah Medical vs. Repro Med Systems | Utah Medical vs. InfuSystems Holdings | Utah Medical vs. Milestone Scientific |
| Bionano Genomics vs. Intuitive Surgical | Bionano Genomics vs. Innovative Eyewear | Bionano Genomics vs. Stereotaxis | Bionano Genomics vs. Nexgel Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |